Journal of Proteomics and Genomics Research

Harsh Kavi, Albert Einstein College of Medicine
Editorial Board

Harsh Kavi

Albert Einstein College of Medicine · United States

Editorial leadership for Journal of Proteomics and Genomics Research ISSN 2326-0793

Research interests

  • Histone Modifications Chromatin Epigenetics Transcription Rna Interference

Biography

  • I am currently engaged in research at the Albert Einstein College of medicine in New York ,USA.
  • I have more than 10 years of experience in the field of chromatin biology and epigenetics. I have about 10 publications in eminent journals such as Science.
  • During my doctoral thesis at the University of Missouri, I studied the role of RNA interference machinery and RNA polymerase II in Drosophila heterochromatin formation.
  • This paper laid the foundation for similar finding in plants and worms.
  • Recently, I am studying the role of linker histone H1 in flies. We published our findings in Science demonstrating the role of H1 in transposon regulation in flies. In addition, I am studying the role of different domains and post-translational modification of H1 in fly gene expression and development.
  • In addition to research I have peer reviewed manuscripts submitted to prestigious journals such as Cell research (Nature publishing group), Genetics, BMC plant biology and African Journal of Biotechnology.
  • I have written 2 book chapters and written several review articles.
  • I have presented my findings at the prestigious Gordon research Conference in USA.
  • I am well versed with latest molecular biology techniques and have in-depth understanding of the basic principles involved in the current techniques used to study gene regulation such as ChIP-seq and RNA-seq. 
  • I am confident that given my expertise and experience I will enrich the editorial quality of your esteemed journal.

Considering JPGR for your work?

This journal is guided by Harsh Kavi (Albert Einstein College of Medicine) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.

Start your submission

Menu